This study investigated changes in muscle activity when subjects are asked to maintain a constant cadence during an unloaded condition. Eleven subjects pedaled for five loaded conditions (220 W, 190 W, 160 W, 130 W, 100 W) and one unloaded condition at 80 rpm. Electromyographic (EMG) activity of six lower limb muscles, pedal forces and oxygen consumption were calculated for every condition. Muscle activity was defined by timing (EMG onset and offset) and level (integrated values of EMGrms calculated between EMG onset and EMG offset) of activation, while horizontal and vertical impulses were computed to characterize pedal forces. Muscle activity, pedal forces and oxygen consumption variables measured during the unloaded condition were compared with those extrapolated to 0 W from the loaded conditions, assuming a linear relationship. The muscle activity was changed during unloaded condition: EMG onset and/or offset of rectus femoris, biceps femoris, vastus medialis, and gluteus maximus muscles were delayed (p<0.05); iEMGrms values of rectus femoris, biceps femoris, gastrocnemius medialis and tibialis anterior muscles were higher than those extrapolated to 0 W (p<0.05). Vertical impulse over the extension phase was lower (p<0.05) while backward horizontal impulse was higher (p<0.05) during unloaded condition than those extrapolated to 0 W. Oxygen consumptions were higher during unloaded condition than extrapolated to 0 W (750+/-147 vs. 529+/-297 mLO(2) x min(-1); p<0.05). Timing of activation of rectus femoris and biceps femoris was dramatically modified to optimize pedal forces and maintain a constant cadence, while systematic changes in the activation level of the bi-articular muscles induced a relative increase in metabolic expenditure when pedaling during an unloaded condition.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jelekin.2008.11.014 | DOI Listing |
BMC Rheumatol
January 2025
Montefiore Medical Center, Albert Einstein College of Medicine, Rheumatology, Bronx, NY, USA.
Background: The anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody-positive dermatomyositis is known for its association with rapidly progressive interstitial lung disease (RP-ILD) and ulcerative skin lesions, often presenting with or without muscle involvement. The aim of this study was to identify distinct clinical and laboratory features that could be used to evaluate disease progression in an ethnically diverse cohort of anti-MDA5 dermatomyositis patients at a U.S.
View Article and Find Full Text PDFSkelet Muscle
January 2025
Department of Molecular Physiology and Biophysics, and Department of Neurology, Howard Hughes Medical Institute, Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center, Roy J. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, Iowa, USA.
Background: Maintaining the connection between skeletal muscle fibers and the surrounding basement membrane is essential for muscle function. Dystroglycan (DG) serves as a basement membrane extracellular matrix (ECM) receptor in many cells, and is also expressed in the outward-facing membrane, or sarcolemma, of skeletal muscle fibers. DG is a transmembrane protein comprised of two subunits: alpha-DG (α-DG), which resides in the peripheral membrane, and beta-DG (β-DG), which spans the membrane to intracellular regions.
View Article and Find Full Text PDFArch Public Health
January 2025
Department of Second Orthopedics, First People's Hospital of Jiashan County, Tiyu South Road 1218#, Jiashan County, Zhejiang, China.
Background: Sarcopenia is an age-related syndrome marked by a gradual decline in skeletal muscle mass and function. While various factors influencing sarcopenia have been studied, the link between daily sedentary time and sarcopenia remains underexplored.
Method: This study analyzed the association between daily sitting time and sarcopenia using data from the National Health and Nutrition Examination Survey (NHANES 2011-2018).
BMC Psychiatry
January 2025
Department of Psychiatry, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, Kanagawa, 236-0004, Japan.
Background: Paliperidone is a second-generation antipsychotic and the main active metabolite of risperidone, formulated to provide consistent therapeutic effects through an extended-release system, designed to provide consistent therapeutic effects through an extended-release formulation. While commonly used in clinical practice, switching from risperidone to paliperidone, particularly during valproate therapy, can pose challenges due to potential pharmacokinetic interactions that may increase the risk of extrapyramidal symptoms (EPS). Despite clinical observations suggesting these interactions, case reports documenting such adverse effects are scarce.
View Article and Find Full Text PDFBMC Geriatr
January 2025
James P. Wilmot Cancer Institute, Rochester, New York, USA.
Background: Older adults with cancer are vulnerable to declines in muscle performance (e.g., strength, speed, duration of muscular contraction), which are associated with worse cancer-related outcomes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!